FindMyKOL
Clinical trialNCT07462507RecruitingPhase 2Interventional

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

SponsorWashington University School of MedicineEnrollment104Brain MetastasesCentral Nervous System Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Adult patients with primary or secondary central nervous system malignancies will be invited to undergo a baseline \[C-11\]-CS1P1 PET scan and a follow-up scan within 24 months of the baseline scan (preferably within 6-months post-treatment).The study will describe patterns of tracer uptake in tumors and normal brain and explore how these patterns relate to MRI findings, treatments received, and clinical outcomes.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Tammie L.S. Benzinger, M.D., Ph.D.

    Washington University School of Medicine

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington University School of Medicine

    St Louis, Missouri, United States

    C. Ryan King, M.D., Ph.D.Esther Lu, Ph.D.G. Richard Benzinger, M.D., Ph.D.Hongyu An, Ph.D.Jiayi Huang, M.D.Matthew R Brier, M.D., Ph.D.Qing Wang, Ph.D.Richard Laforest, Ph.D.Tammie L.S. Benzinger, M.D., Ph.D.Yong Wang, Ph.D.Zhude Tu, Ph.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

[C-11]-CS1P1
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Apr 2026
Primary completion
30 Jun 2031
Completion
30 Jun 2033
Last update posted
21 Apr 2026
Registered enrollment
104
Registry id
NCT07462507
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.